Top 30 Life Science VC Funds & Investors in Singapore (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
EDBI
VC Fund
|
3 | United States, Singapore, India | Series C, Series B, Series D | Biotechnology, Software, Health Care | $12M–$400M |
|
Antler
VC Fund
|
2 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Bossa Invest
VC Fund
|
2 | United States, Brazil, Mexico | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Financial Services | $50k–$50M |
|
Eisai
VC Fund
|
2 | Japan, United States, China | Series A, Series C, Grant | Medical, Biotechnology, Health Care | $881k–$100M |
|
Partners Investment
VC Fund
|
2 | South Korea, United States, Japan | Series A, Series B, Series C | Biotechnology, Health Care, Software | $2.5M–$98M |
|
Anzu Partners
VC Fund
|
2 | United States, Canada, Spain | Series A, Series B | Software, Biotechnology, Manufacturing | $5M–$55M |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
2 | Japan, United States, India | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $2.5M–$100M |
|
Prox Ventures
VC Fund
|
1 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $2.5M–$28M |
|
Altara Ventures
VC Fund
|
1 | Indonesia, Singapore, Philippines | Series A, Series B, Series C | Information Technology, FinTech, Software | $3.9M–$70M |
|
Hana Financial Investment
VC Fund
|
1 | South Korea, Singapore, India | Series A, Series B, Seed | Biotechnology, Information Technology, Artificial Intelligence | $213k–$26M |
|
Openspace Capital
VC Fund
|
1 | Singapore, Indonesia, Philippines | Series A, Series B, Seed | E-Commerce, Financial Services, Software | $1.9M–$35M |
|
Amgen Ventures
VC Fund
|
1 | United States, Canada, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.4M–$110M |
|
KB Financial Group
VC Fund
|
1 | South Korea, India, Vietnam | Series A, Series B, Series D | Financial Services, Software, SaaS | $1M–$104M |
|
Nestle
VC Fund
|
1 | United States, United Kingdom, Germany | Corporate Round, Grant, Private Equity | Food and Beverage, Health Care, Food Processing | $6k–$4.2B |
|
M Capital Partners
VC Fund
|
1 | France, United States, Canada | Seed, Series A | Health Care, Software, Food and Beverage | $1.1M–$6.8M |
|
Animoca Brands
VC Fund
|
1 | United States, United Kingdom, Singapore | Seed, Series A | Blockchain, Gaming, Cryptocurrency | $1.5M–$40M |
|
IBK Capital
VC Fund
|
1 | South Korea, United States, India | Series A, Seed, Series B | Health Care, Biotechnology, Information Technology | $2k–$22M |
|
Seeds Capital
VC Fund
|
1 | Singapore, United States, Hong Kong | Seed, Series A, Series B | Biotechnology, Artificial Intelligence, Health Care | $767k–$45M |
|
K3 Ventures
VC Fund
|
1 | Singapore, United States, Indonesia | Series A, Seed | Financial Services, FinTech, Software | $1.2M–$100M |
|
Temasek
VC Fund
|
1 | United States, China, India | Series B, Series C, Series D | Biotechnology, Health Care, Software | $29M–$450M |
|
Enterprise Singapore
VC Fund
|
1 | Singapore, United States, United Kingdom | Grant, Seed, Pre-Seed | Information Technology, Software, Artificial Intelligence | $17k–$1.8M |
|
Hatcher+
VC Fund
|
1 | United States, Italy, Australia | Pre-Seed, Seed, Convertible Note | Software, Information Technology, Health Care | $50k–$1.2M |
|
Elev8.VC
VC Fund
|
1 | Singapore, United States, Germany | Seed, Series A | Health Care, Software, Biotechnology | $1M–$13M |
|
Gaorong Capital
VC Fund
|
1 | China, United States, Hong Kong | Series A, Series B, Seed | Information Technology, Software, Artificial Intelligence | $2.8M–$110M |
|
KT Investment
VC Fund
|
1 | South Korea, United States, Singapore | Series A, Series B, Series C | Artificial Intelligence, Software, Information Technology | $1.7M–$109M |
|
SK Securities
VC Fund
|
1 | South Korea, United States, Singapore | Series A, Seed, Series B | Apps, Health Care, Information Technology | $316k–$24M |
|
Lightstone Ventures
VC Fund
|
1 | United States, Ireland, India | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7M–$105M |
|
Alameda Research
VC Fund
|
1 | United States, Singapore, United Kingdom | Seed, Venture - Series Unknown, Series A | Blockchain, Cryptocurrency, Financial Services | $250k–$40M |
|
Shinhan Investment
VC Fund
|
1 | South Korea, United States, Bermuda | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $12k–$106M |
|
Medici Investment
VC Fund
|
1 | South Korea, Singapore, United States | Series A, Series C, Series B | Biotechnology, Medical, Software | $1.9M–$250M |
| Access all 57 VC funds in Singapore Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series C, Series B, Series D
- Geography: United States, Singapore, India
Investor stats
- Total investments: 194
- Round size: Series B $20M–$170M; Series C $12M–$275M; Series D $17M–$400M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Paxata — The DataRobot End-of-Life (EOL) policy helps manage product lifecycle phases in a way that is transparent and clear for customers who will seamlessly transition to a new product or service.
- Rotimatic — Rotimatic uses IoT and AI technologies to measure ingredients, knead dough, roll it out, cook, and shape perfectly round flatbreads in sequence. The system supports consistency, portion control, and customizable ingredient mixtures, allowing users to tailor recipes to dietary preferences. Rotimatic’s product is designed to simplify the process ofpreparing flatbreads, reducing time and physical effort.At Zimplistic, our mission is to tackle real-world problems to improve the daily lives of people. This gave rise to Rotimatic, our flagship product. It is the world's first kitchen robot that makes fresh, healthy, homemade rotis with a touch of a button.About Rotimatic - Rotimatic is a roti-making appliance that uses artificial intelligence to make rotis (flatbreads) without the need for human supervision. It is a fully automatic robot that processes all the essential ingredients and produces hot and delicious rotis in under a minute.Rotimatic is a technology marvel, packed with some cutting-edge technology innovated by a talented group of health-conscious people. A complete game changer globally - it is compact, user-friendly, and makes preparing rotis a cakewalk. Since its launch in 2016, Rotimatic has disrupted the kitchen appliances segment by piquing the interest of many.By knocking the hassle out of healthy eating, and helping everyone eat fresh food made at home with handpicked ingredients, we believe that people will eat healthier and live better with Rotimatic. It's become a worldwide kitchen sensation with over 3 million rotis served in thousands of households until June 2017.Rotimatic is available for purchase in Singapore, US, UK, Canada, Australia, and New Zealand. Order now - https://rotimatic.com/order/
- TriReme Medical — TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2214
- Round size: Seed $159k–$4.6M; Pre-Seed $100k–$645k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $72M in 2024
Portfolio highlights
- iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Homethings — Single-use plastic is bonkers. Homethings makes cleaning products that make sense. No more shipping water in plastic bottles. We send non toxic cleaning tabs so that you can refill over and over again using your tap.
Aprenda a Investir em Startups
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Brazil, Mexico
Investor stats
- Total investments: 1322
- Round size: Seed $193k–$6M; Pre-Seed $50k–$1.3M; Venture - Series Unknown $703k–$50M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $362k in 2019
Portfolio highlights
- Sandwiche — Sandwiche creates customizable link in bio pages enabling social media monetization and affiliate marketing management.
- Sukha — An all-in-one focus app and distraction blocker for Mac, Windows and Chromebook: AI tasks, binaural music, website and phone blocking, Pomodoro timers.
- Elemeno Health — Elemeno Health is an intuitive, cloud-based app, customized to specific needs of your hospital or unit. Streamline training and communication, drive best practices, and empower your staff with just-in-time access to critical information.
Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical business that operates in business groups and focuses on oncology and neurology, dementia-related diseases, and neurodegenerative diseases.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Series A, Series C, Grant
- Geography: Japan, United States, China
Investor stats
- Total investments: 20
- Round size: Series A $3M–$51M; Series C $881k–$100M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Medefer — At Medefer, we want to be the world’s most patient-focused virtual health serviceWe are on a mission to help patients get better faster. We are starting by partnering with the NHS to build the best outpatient process, helping assess patients more quickly.To do this work with our partners, we provide technology-enabled clinical and operationalexpertise, making it better for patients, healthcare professionals and the NHS.
- Head Diagnostics — Innovating Brain Health, Transforming Lives. We empower you with clinically validated AI-driven digital solutions designed to support diagnosis and enhance the detection and management of neurological disease with a focus on cognitive assessment
- Beren Therapeutics — Founded to serve patients through transformative medicines
As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Series C
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 130
- Round size: Series A $2.5M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
- Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
- Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 78
- Round size: Series A $6M–$25M; Series B $5M–$55M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — raised $100M in 2024
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- EnCharge AI — AI Compute from the Edge-to-Cloud for Every Business. Transformative technology for AI computation, breaking records in efficiency and sustainability to enable state-of-the-art models uninhibited by power, space, and cost constraints.
- South 8 Technologies — South 8's LiGas cells are engineered to deliver unmatched performance and safety in the most demanding environments.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: Japan, United States, India
Investor stats
- Total investments: 195
- Round size: Seed $2.5M–$35M; Series A $2.8M–$64M; Series B $2.8M–$100M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- TXP Medical — TXP Medical build a next-generation medical system through acute care.
- Startbahn — Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We alsorun joint projects with other companies.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $2.5M–$14M; Series A $2.8M–$28M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.
Show more...Investment focus
- Industry: Information Technology, FinTech, Software
- Stage:Series A, Series B, Series C
- Geography: Indonesia, Singapore, Philippines
Investor stats
- Total investments: 24
- Round size: Series A $4.5M–$13M; Series B $3.9M–$40M; Series C $12M–$70M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Saturdays — Shop for premium quality glasses at affordable prices with free shipping and 30-day return policy. Find your perfect pair with SATURDAYS LIFESTYLE.
- Netbank — Netbank provides various banking solutions like alternative lenders, payment solutions, neobanks, and wallets.
- PolicyStreet — Renew your insurance and road tax instantly, hassle-free. We're the BEST, but don't just take our word for it. See what our happy customers have to say!
Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: South Korea, Singapore, India
Investor stats
- Total investments: 92
- Round size: Seed $213k–$7.9M; Series A $2M–$26M; Series B $1.7M–$26M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Trustay — Trustay is a real estate asset management company.
- earlysloth — Earlysloth is an AI based survey on the messenger for the enterprise.
- Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Software
- Stage:Series A, Series B, Seed
- Geography: Singapore, Indonesia, Philippines
Investor stats
- Total investments: 133
- Round size: Seed $2.6M–$13M; Series A $1.9M–$20M; Series B $10M–$35M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Rotimatic — Rotimatic uses IoT and AI technologies to measure ingredients, knead dough, roll it out, cook, and shape perfectly round flatbreads in sequence. The system supports consistency, portion control, and customizable ingredient mixtures, allowing users to tailor recipes to dietary preferences. Rotimatic’s product is designed to simplify the process ofpreparing flatbreads, reducing time and physical effort.At Zimplistic, our mission is to tackle real-world problems to improve the daily lives of people. This gave rise to Rotimatic, our flagship product. It is the world's first kitchen robot that makes fresh, healthy, homemade rotis with a touch of a button.About Rotimatic - Rotimatic is a roti-making appliance that uses artificial intelligence to make rotis (flatbreads) without the need for human supervision. It is a fully automatic robot that processes all the essential ingredients and produces hot and delicious rotis in under a minute.Rotimatic is a technology marvel, packed with some cutting-edge technology innovated by a talented group of health-conscious people. A complete game changer globally - it is compact, user-friendly, and makes preparing rotis a cakewalk. Since its launch in 2016, Rotimatic has disrupted the kitchen appliances segment by piquing the interest of many.By knocking the hassle out of healthy eating, and helping everyone eat fresh food made at home with handpicked ingredients, we believe that people will eat healthier and live better with Rotimatic. It's become a worldwide kitchen sensation with over 3 million rotis served in thousands of households until June 2017.Rotimatic is available for purchase in Singapore, US, UK, Canada, Australia, and New Zealand. Order now - https://rotimatic.com/order/
- Every Half Coffee Roasters — Roasting & Brewing finest quality of specialty coffee bean from Vietnam and the world. We believe that every half bean has its soulmate. Let's find yours
- Love, Bonito — Love, Bonito is the best and largest vertically integrated, omni-channel women’s fashion brand in the region. Founded in 2010, she has grown to 150 people strong, proudly headquartered in Singapore with country offices in Indonesia, Malaysia, and Hong Kong and an omni-channel presence across these 4 markets, plus an international e-commerce sitethat ships globally.Love, Bonito is redefining what retail means - thoughtful, experiential, community-driven - with sights set on becoming the most thoughtful brand globally, for the everyday woman.
Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 116
- Round size: Series A $4.4M–$53M; Series B $11M–$110M; Series C $19M–$80M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $100M in 2012
Portfolio highlights
- EnClear Therapies — EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will targetimproving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
- Ember LifeSciences — Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container providescontinuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases.
- Mindset Medical — Medical Mindset is your health companion. It is a platform for you to track your health and wellness.
KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.
Show more...Investment focus
- Industry: Financial Services, Software, SaaS
- Stage:Series A, Series B, Series D
- Geography: South Korea, India, Vietnam
Investor stats
- Total investments: 14
- Round size: Series A $1M–$45M; Series B $7.8M–$104M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
- Wavebridge — Wavebridge is a top-tier institutional digital asset company with expertise in both traditional and crypto finance. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
- Ohouse — No.1 Interior Onestop Platform
Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.
Show more...Investment focus
- Industry: Food and Beverage, Health Care, Food Processing
- Stage:Corporate Round, Grant, Private Equity
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 20
- Round size: Grant $6k–$150k; Private Equity $130M–$4.2B; Corporate Round $100M–$229M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Drools — Discover Drools, the best dog food brand offering premium nutrition for your furry friend. Explore our range of healthy, vet-recommended dog food to keep your pet happy and healthy.
- Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
- Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Industry: Health Care, Software, Food and Beverage
- Stage:Seed, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 113
- Round size: Seed $1.1M–$5.4M; Series A $3.3M–$6.8M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Haiku — L'IA et la data au service des du droit
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
- Ascendance — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security,and new business models.
Show more...Investment focus
- Industry: Blockchain, Gaming, Cryptocurrency
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 504
- Round size: Seed $1.5M–$10M; Series A $5M–$40M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Vangrid — Vangrid operates as a decentralized physical infrastructure network.
- Dow Protocol — An E-Commerce Financing RWA Platform on @BNBCHAIN, facilitating assets trusted by the world's largest banks. Lead invested by @mhventures @Maple_block
- Ceramic Network — We've joined @textileio to build the first open intelligence network for AI agents. Follow us there.
IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: South Korea, United States, India
Investor stats
- Total investments: 114
- Round size: Seed $2k–$4M; Series A $1.5M–$9.8M; Series B $12k–$22M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- MID — MID specializes in the development, testing, and production of space-related components.
- FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
- Automata — Automata builds ontology-driven enterprise systems that execute. Zenith verifies decisions, grades knowledge, and turns institutional memory into software you can run.
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: Singapore, United States, Hong Kong
Investor stats
- Total investments: 146
- Round size: Seed $767k–$6M; Series A $2.4M–$21M; Series B $5M–$45M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Pints AI — Unlock global and private financial data with AI like never before.
- ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
- Protuoso Biosciences — Protuoso Bio is a pioneering biotechnology company developing Next-Gen MUXBODIES for Complex Diseases. We leverage AI-driven protein engineering and synthetic biology to advance innovative oncology drug research.
K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Series A, Seed
- Geography: Singapore, United States, Indonesia
Investor stats
- Total investments: 96
- Round size: Seed $1.2M–$20M; Series A $2M–$100M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- iEduGPT — iEduGPT is an AI-powered learning platform based in Singapore that offers personalized, adaptive learning solutions for professional and academic exam preparation. It leverages artificial intelligence to analyze individual learners' strengths and knowledge gaps and create optimized study paths. The platform aims to transform exam preparationby making learning smarter, more efficient, and tailored to each user’s unique needs, covering certifications in finance, academics, and languages.
- Rekosistem — Rekosistem is a Clean- & Climate-Tech Company that enables circular economy implementation in the waste supply chain by leveraging proprietary waste management operation systems to transform waste into recycled materials and renewable resources.
- Octopus Power — Octopus Power develops physics-based artificial intelligence systems focused on physical AGI, enabling machines to perceive, reason, and act within real-world environments. The company builds models that integrate physical laws with data-driven learning to support embodied intelligence, allowing systems to interact with and adapt to dynamicphysical conditions. Its technology is designed to move beyond purely digital AI by incorporating simulation, control systems, and real-world feedback loops into intelligent decision-making.The platform supports applications in robotics, industrial automation, and complex physical systems where understanding motion, force, and environmental constraints is essential. It leverages continuous learning mechanisms that allow systems to evolve over time, improving performance through interaction and data accumulation. Octopus Power also develops infrastructure for training and deploying these models, including simulation environments and tools for integrating AI with physical hardware.
Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series C, Series D
- Geography: United States, China, India
Investor stats
- Total investments: 558
- Round size: Series B $29M–$300M; Series C $30M–$400M; Series D $45M–$450M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Rize — Rize is an AgTech startup formed through a joint venture between Temasek, Wavemaker Impact, Breakthrough Energy Ventures, GenZero to decarbonize rice cultivation in Asia.
- Xforceplus — Xforceplus develops enterprise collaborative solutions of software as a service. The company provides internet-based and cloud-innovated supply chain collaboration and invoice management software encompassing supply chain settlement, real-time electronic account, tax reporting, tax analysis, electronic invoicing, and other related areas, enablingbusinesses to increase tax revenue, release capital vitality, and ensure financial security.
- Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Enterprise Singapore is a government agency that supports enterprise development.The company works with committed companies to build capabilities, innovate and internationalize. Enterprise Singapore also supports the growth of Singapore as a hub for global trading and startups. As the national standards and accreditation body, the companycontinues to build trust in Singapore’s products and services through quality and standards.To enable businesses navigate today’s enterprise landscape, Enterprise Singapore adopts a company-centric approach. Enterprise Singapore do so, by providing programmes and support catered to your company’s stage of growth, the industry you are in, and the overseas markets of your interest.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Grant, Seed, Pre-Seed
- Geography: Singapore, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $300k–$1.8M; Grant $17k–$585k; Pre-Seed $40k–$300k
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Goldilock — Goldilock is a revolutionary cybersecurity solution that enables users to physically connect and disconnect their digital assets, devices, networks, and critical infrastructure from the internet without using the internet itself. The patented remote security technology ensures that sensitive data remains secure and accessible only when needed
- Pride Health — Access trusted doctors, e-prescriptions, and discreet medication delivery. Safe, convenient, and judgment-free.
- 2Strands Biosciences — Better, Cheaper and Faster!
Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: United States, Italy, Australia
Investor stats
- Total investments: 179
- Round size: Seed $50k–$1M; Pre-Seed $75k–$1.2M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Inaam — impact investing made simple. pick your values, build a real portfolio, track where your money goes. $10/month. ASIC-regulated. built for 18-30s.
- PayToMe.co — PayToMe.co offers innovative and secure payment solutions including text-to-pay, digital invoicing, and digital checkbook services.
- Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Deep Dive Into Deep Tech
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: Singapore, United States, Germany
Investor stats
- Total investments: 26
- Round size: Seed $1M–$4.8M; Series A $3.5M–$13M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Polybee — Polybee develops autonomous drone systems designed for agricultural applications. They focus on automating yield forecasting and pollination using drones, computer vision, and artificial intelligence. Their technology aims to reduce uncertainty in agriculture by providing solutions for seed companies, vertical farming operations, and greenhousecooperatives. Polybee's innovations are particularly useful in environments.
- Terra Oleo — Terra Oleo pioneers microbial technology to create sustainable fats & oils, offering cost-effective alternatives to palm oil & cocoa butter.
- 2Strands Biosciences — Better, Cheaper and Faster!
Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 291
- Round size: Seed $4.1M–$62M; Series A $2.8M–$75M; Series B $14M–$110M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $1.2B in 2020
Portfolio highlights
- Genta Kyushu Bio — Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies.
- Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
- Mochi Intelligence — Mochi Intelligence is a high-tech enterprise specializing in the research and development of embodied intelligent robots. The company is committed to creating intelligent robots including humanoid robots that can truly understand and adapt to the real world through cutting-edge artificial intelligence technology and robotics.
KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Series A, Series B, Series C
- Geography: South Korea, United States, Singapore
Investor stats
- Total investments: 86
- Round size: Series A $1.7M–$26M; Series B $5.9M–$104M; Series C $7.4M–$109M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Nums AI — Nums AI is a single foundation model that predicts across commerce, healthcare, finance, manufacturing, and defense.
- MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
- Twinny — Twinny specializes in the development of self-driving robots.
SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.
Show more...Investment focus
- Industry: Apps, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: South Korea, United States, Singapore
Investor stats
- Total investments: 53
- Round size: Seed $316k–$2.2M; Series A $1.5M–$24M; Series B $5.7M–$24M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- InnoDtech — InnoDtech creates AI dental diagnostics and clear orthodontic aligners using 3D imaging, modeling, and personalized treatment planning.
- Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services. Currently, Quantum AI is providing various services centered on the financial sector, including AI document processing automation, intelligent voice consultation, assetization of unstructured financial data based on its own language model, and AIsearch. Utilizing a proprietary AI recognition engine, the company has integrated and analyzed various data sources, including financial documents, customer consultation history, and market news, and have carried out numerous AI data assetization projects for major domestic commercial banks and insurance companies.
- Buysell Standards — Buysell Standards is the provider of manpower supply and employment arrangement services.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, India
Investor stats
- Total investments: 85
- Round size: Series A $7M–$95M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
- Crystalys Therapeutics — Transforming care for people living with gout.
Alameda Research is a quantitative cryptocurrency trading firm that provides liquidity in cryptocurrency and digital assets markets. It was founded in 2017 and is headquartered in Central and Western, Hong Kong.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Financial Services
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 321
- Round size: Seed $1M–$8M; Series A $2.7M–$35M; Venture - Series Unknown $250k–$40M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- 3Commas — 3Commas develops a crypto-asset management tool for tracking investments and exchanges in a unified platform. It provides access to a unified dashboard as the central hub for trading and portfolio management execution.
- Fuel Labs — At Fuel, we are building the fastest execution layer for the modular blockchain stack.
- Optim Finance — Optim Finance provides investment tools that optimize yield on digital assets. Their financial primitives enable users to rent ADA delegation rights to power novel use cases such as SPO loans, leverage into ISOs, and initial bonds.
Shinhan Investment Corp. is a financial services company based out of 여의대로 70, 영등포구, 서울특별시, South Korea.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: South Korea, United States, Bermuda
Investor stats
- Total investments: 35
- Round size: Series A $1.4M–$23M; Series B $12k–$52M; Series C $26M–$106M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Inocras — Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
- 24X Bermuda — 24X Bermuda operates an electronic brokerage platform that facilitates foreign exchange (FX) spot transactions for institutional users. The company addresses market challenges such as fragmented pools of liquidity and high access fees. It also holds a 'Class T' Cryptocurrency DABA License, allowing it to offer cryptocurrency tradingservices. The platform is designed to introduce both US and non-US institutional clients to efficient and cost-effective trading solutions.
- Sensor Tower — Sensor Tower provides market intelligence and analytics for the mobile app economy through their software suite. It serves independent and Fortune 500 customers alike, spanning the mobile games, travel, music, finance, eCommerce, and entertainment markets. Our suite consists of free, SMB, and Enterprise level solutions including Store Intelligence,Usage Intelligence, Ad Intelligence, and App Intelligence.
Venture Capital firm in South Korea.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Series A, Series C, Series B
- Geography: South Korea, Singapore, United States
Investor stats
- Total investments: 33
- Round size: Series A $1.9M–$15M; Series B $7.8M–$27M; Series C $2.9M–$250M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- MID — MID specializes in the development, testing, and production of space-related components.
- RebuilderAI — A new way to bring imagination into the real world
- Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Life Science VC funding in Singapore at a glance
Stats across 32 deals from 57 investors.
Access all 57 VC funds in Singapore Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 57 VC funds investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!